Immunotherapy News and reporting on cancer immunotherapy. Sep 15, 2022 BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development Aug 24, 2022 Roche Gets Expanded CE Mark for Ventana PD-L1 Assay to ID NSCLC Patients for Tecentriq Jul 21, 2022 PamGene Gains CE-IVD Registration for Immunotherapy Guidance Tests Jun 22, 2022 Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer Premium Jun 15, 2022 Blood-Based PD-L1 Tracking Could Offer Improved Response Prediction for Lung Cancer Immunotherapy Premium Jun 13, 2022 OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies Jun 2, 2022 InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma Premium May 10, 2022 OncoHost Raises $35M in Series C Financing Apr 7, 2022 Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study Premium Nov 24, 2021 Netherlands' PamGene Plans to Launch Dx Services for Lung Cancer, Melanoma Treatment Selection Premium Nov 11, 2021 Oncocyte Aims to Stand Out in Cancer Therapy Selection Market with 2022 Test Launches Premium Sep 21, 2021 Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy Aug 18, 2021 FDA Approves GlaxoSmithKline's Jemperli, Roche’s Ventana CDx for dMMR Solid Cancers Jul 1, 2021 European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response Jun 3, 2021 Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer May 2, 2021 Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses Premium Apr 13, 2021 Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay Apr 12, 2021 Singapore, MIT Researchers Develop Immune Response Test to Improve Infectious Disease Diagnosis Premium Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Load More Breaking News Quest Diagnostics Enters Lab Deal With Maine Healthcare System Northern Light Health Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance Diazyme Gets FDA Emergency Use Authorization for SARS-CoV-2 Antibody Test HHS Report Identifies Labs Billing for Unusually High Amounts of COVID-19 Add-on Testing FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy DiaSorin, PerkinElmer, Roche, Others Nab FDA 510(k) Clearances in November
